Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Mersana Therapeutics buy Citigroup Inc.

Mersana Therapeutics
Start price
€1.71
04.12.23 / 50%
Target price
€4.61
04.12.24
Performance (%)
25.26%
End price
€2.14
05.12.24
Summary
This prediction ended on 05.12.24 with a price of €2.14. The prediction had a final performance of 25.26%. Citigroup_Inc_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Mersana Therapeutics - - -
iShares Core DAX® 2.331% 5.140% 25.000%
iShares Nasdaq 100 2.077% 2.956% 8.935%
iShares Nikkei 225® 2.759% 7.214% 22.171%
iShares S&P 500 1.613% 2.893% 6.249%

Comments by Citigroup_Inc_ for this prediction

In the thread Mersana Therapeutics diskutieren
Prediction Buy
Perf. (%) 25.26%
Target price 4.606
Change
Ends at 04.12.24

Mersana Therapeutics, Inc. (NASDAQ: MRSN) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $5.00 price target on the stock, up previously from $1.00.
Ratings data for MRSN provided by MarketBeat

Citigroup Inc. 
0
Report Share
04.12.23
In the thread Trading Mersana Therapeutics
Prediction Buy
Perf. (%) 25.26%
Target price 4.606
Change
Ends at 04.12.24

Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten

Citigroup Inc. 
0
Report Share
05.12.24

Stopped prediction by Citigroup_Inc_ for Mersana Therapeutics

buy
Mersana Therapeutics

Start price
Target price
Perf. (%)
€2.40
15.11.24
€4.74
15.11.25
-89.06%
16.11.25

Citigroup Inc. 
15.11.24 50%
buy
Mersana Therapeutics

Start price
Target price
Perf. (%)
€1.34
27.08.24
€4.48
27.08.25
-84.11%
28.08.25

Citigroup Inc. 
27.08.24 50%